Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $21 at Piper Sandler
Tweet
Share
E-mailGet Alerts BHVN Hot Sheet
Price: $14.64 -1.41%
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst Christopher J. Raymond lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $21.00 (from $23.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Biohaven Pharma (BHVN) PT Raised to $23 at RBC Capital
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
- Biohaven Pharma (BHVN) PT Raised to $19 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT Change, Hot CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
